April 16, 2013; 80 (16) Article
Autosomal dominant vasovagal syncope
Clinical features and linkage to chromosome 15q26
Karl Martin Klein, Catherine J. Bromhead, Katherine R. Smith, Christopher J. O’Callaghan, Susan J. Corcoran, Sarah E. Heron, Xenia Iona, Bree L. Hodgson, Jacinta M. McMahon, Kate M. Lawrence, Ingrid E. Scheffer, Leanne M. Dibbens, Melanie Bahlo, Samuel F. Berkovic
First published April 15, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31828cfad0
Karl Martin Klein
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Catherine J. Bromhead
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Katherine R. Smith
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Christopher J. O’Callaghan
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Susan J. Corcoran
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Sarah E. Heron
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Xenia Iona
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Bree L. Hodgson
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Jacinta M. McMahon
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Kate M. Lawrence
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Ingrid E. Scheffer
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Leanne M. Dibbens
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Melanie Bahlo
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Samuel F. Berkovic
From the Epilepsy Research Centre (K.M.K., J.M.M., K.M.L., I.E.S., S.F.B.), Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Australia; Epilepsy Center Hessen (K.M.K.), Department of Neurology, University Hospitals Giessen & Marburg, and Philipps-University Marburg, Marburg, Germany; The Walter and Eliza Hall Institute of Medical Research (C.J.B., K.R.S., M.B.), Parkville; Departments of Medical Biology (K.R.S.) and Mathematics and Statistics (M.B.), The University of Melbourne, Parkville; Department of Clinical Pharmacology (C.O.), Austin Health and Department of Medicine, University of Melbourne, Heidelberg; Baker IDI Heart and Diabetes Institute (S.J.C.), Melbourne; Epilepsy Research Program (S.E.H., X.I., B.L.H., L.M.D.), School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide; Department of Paediatrics (I.E.S.), University of Melbourne, Royal Children's Hospital, Parkville; and Florey Neuroscience Institutes (I.E.S.), Heidelberg, Australia.
Autosomal dominant vasovagal syncope
Clinical features and linkage to chromosome 15q26
Karl Martin Klein, Catherine J. Bromhead, Katherine R. Smith, Christopher J. O’Callaghan, Susan J. Corcoran, Sarah E. Heron, Xenia Iona, Bree L. Hodgson, Jacinta M. McMahon, Kate M. Lawrence, Ingrid E. Scheffer, Leanne M. Dibbens, Melanie Bahlo, Samuel F. Berkovic
Neurology Apr 2013, 80 (16) 1485-1493; DOI: 10.1212/WNL.0b013e31828cfad0
Citation Manager Formats
Make Comment
See Comments
Downloads
290
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.